About SfPM

Functional precision medicine is at an inflection point in cancer care. Genomics has transformed oncology, yet molecular data alone still falls short in predicting patient responses. The next decade requires marrying tumor profiling with systematic, scalable functional testing directly on patient-derived tissue and models to guide therapy, accelerate discovery, and benefit patients.

The time is now: organoids, tissue models, single-cell profiling, artificial intelligence, and related technologies are now mature enough to inform both clinical decision-making and drug development, while the policy environment is increasingly receptive to evidence-driven implementation. SfPM is seizing this moment to unite researchers, clinicians, biopharma, funders, and patient advocates around a shared national vision: making functional precision medicine a rigorous, clinically actionable, and measurable part of how we use precision medicine to treat cancer.

Over the next several years, SfPM is focused on four priorities:

  • A national strategic plan: defining the roadmap academia, biopharma, government, and patient groups must take together to move the field forward.

  • An expanded community: broadening the expertise and representation, driving functional precision medicine through inclusive events and new collaborations.

  • A funders coalition: building relationships with governmental and non-governmental funders to catalyze early high-impact projects.

  • Flagship projects: coordinated, high-impact initiatives that demonstrate what the field can achieve together.

Board of Directors

A woman with shoulder-length red hair wearing a black long-sleeve top standing with arms crossed in front of a modern building with glass windows.
A man with gray hair wearing a dark blazer and a checkered shirt, standing with arms crossed against a white background.
A woman with light brown hair and blue eyes smiling, wearing a white jacket with the logo of Prinses Máxima Centrum on the left side.
A man with blue eyes, short light brown hair, and wearing a blue shirt, smiling in an indoor setting.

Karin Langenberg, MD, PhD

Vice President

Princess Máxima Center for Pediatric Oncology

Keith Ligon, MD, PhD

Secretary

Dana-Farber Cancer Institute, Harvard Medical School

A portrait of a man with short brown hair, fair skin, wearing a light blue button-up shirt, looking directly at the camera with a neutral expression.

Jeff Tyner, PhD

Treasurer

Oregon Health Sciences University

Noah Berlow, PhD

Board Member

First Ascent Biomedical

Close-up of a man with dark hair, brown eyes, and light stubble, smiling at the camera, in an indoor setting.
Close-up portrait of a smiling man with short gray hair, beard, glasses, wearing a light blue shirt, against a gray background.
A man with dark hair, wearing a suit jacket and a light blue dress shirt, smiling at the camera against a plain gray background.

Bruce Yeager

Board Member - Commercial Sector

G2E Enterprises, Inc.

Jesse Boehm, PhD

Co-President

Massachusetts Institute of Technology

Alice Soragni, PhD

Co-President

University of Colorado Anschutz

Christian Regenbrecht, PhD

Board Member - Commercial Sector

GSK

Joan Montero, PhD

Board Member

University of Barcelona

Former Directors

A woman with dark, wavy hair smiling outdoors near a tree.

Diana Azzam, PhD

Florida International University

Portrait of a smiling woman with short hair wearing a blue shirt against a neutral background.

Sara Cherry, PhD

University of Pennsylvania

A man with curly gray hair and glasses, smiling, wearing a dark collared shirt.

Chris Kemp, PhD

Fred Hutchinson Cancer Research Center

A man wearing glasses and a white medical coat with a name tag, smiling in a clinical setting.

Anthony Letai, MD, PhD

Director, National Cancer Institute